A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin. Arevalo-Martin A, Molina-Holgado E, Guaza C Neuropharmacology. 2012 Apr 27. PMID: 22561283. Abstract CommentRecommendBookmarkWatch